Retinal vasculopathy in a family with autosomal dominant dyskeratosis congenita Retinal Vasculopathy in a Family with AD-DKC

Ophthalmic Genetics

Volumn 30, Issue 4, 2009, Pages 181-184

  Johnson, Charles A ^a   Hatfield, Mark ^b   Pulido, Jose S ^c  

^a BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^b Retina Consultants   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Dyskeratosis congenita; Genetic anticipation; Retinal vasculopathy

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BLOOD EXAMINATION; CASE REPORT; CLINICAL EXAMINATION; DYSKERATOSIS CONGENITA; FAMILY HISTORY; FEMALE; FLUORESCENCE ANGIOGRAPHY; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; LOW LEVEL LASER THERAPY; MALE; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA DISEASE; RETINA ISCHEMIA; RETINA MACULA EDEMA; RETINA VASCULAR DISEASE; TELANGIECTASIA; TERC GENE;

ADULT; ANTICIPATION, GENETIC; DYSKERATOSIS CONGENITA; FEMALE; FLUORESCEIN ANGIOGRAPHY; GENES, DOMINANT; HUMANS; ISCHEMIA; MACULAR EDEMA; MALE; MIDDLE AGED; RETINAL HEMORRHAGE; RETINAL VESSELS; TOMOGRAPHY, OPTICAL COHERENCE; YOUNG ADULT;

EID: 70350446780     PISSN: 13816810     EISSN: 17445094     Source Type: Journal    
DOI: 10.3109/13816810903148012     Document Type: Article

References (22)

1. Dokal I. Dyskeratosis congenita in all its forms. Br J Haematol. 2000;110(4):768-779.
2. Marrone A, Walne A, Dokal I. Dyskeratosis congenita: Telomerase, telomeres and anticipation. Curr Opin Genet Dev. 2005;15(3):249-257.
3. Vulliamy TJ, Dokal I. Dyskeratosis congenita: The diverse clinical presentation of mutations in the telomerase complex. Biochimie. 2008;90(1):122-130. (Pubitemid 350216210)
4. Sirinavin C, Trowbridge AA. Dyskeratosis congenita: Clinical features and genetic aspects. Report of a family and review of the literature. J Med Genet. 1975;12(4): 339-354.
5. Davidson HR, Connor JM. Dyskeratosis congenita. J Med Genet. 1988;25(12):843-846.
6. Teixeira LF, Shields CL, Marr B, Horgan N, Shields JA. Bilateral retinal vasculopathy in a patient with dyskeratosis congenita. Arch Ophthalmol. 2008;126(1): 134-135.
7. Nazir S, Sayani N, Phillips PH. Retinal hemorrhages in a patient with dyskeratosis congenita. J AAPOS. 2008;12(4):415-417.
8. Vulliamy TJ, Marrone A, Knight SW, Walne A, Mason PJ, Dokal I. Mutations in dyskeratosis congenita: Their impact on telomere length and the diversity of clinical presentation. Blood. 2006;107(7):2680-2685.
9. Bessler M, Du HY, Gu B, Mason PJ. Dysfunctional telomeres and dyskeratosis congenita. Haematologica. 2007;92(8):1009-1012.
10. Vulliamy T, Marrone A, Goldman F, Dearlove A, Bessler M, Mason PJ, Dokal I. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature. 2001;413(6854):432-435. (Pubitemid 32928599)
11. Feng J, Funk WD, Wang S, Weinrich SL, Avilion AA, Chiu C, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider CW, Villeponteau B. The RNA component of human telomerase. Science. 1995;1;269(5228):1236-1241.
12. Jády BE, Richard P, Bertrand E, Kiss T. Cell cycle-dependent recruitment of telomerase RNA and Cajal bodies to human telomeres. Mol Biol Cell. 2006;17(2):944-954.
13. Greider CW, Blackburn EH. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature. 1989;337(6205):331- 337.
14. Yu GL, Bradley JD, Attardi LD, Blackburn EH. In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs. Nature. 1990;344(6262):126-132.
15. Armanios M, Chen JL, Chang YP, Brodsky RA, Hawkins A, Griffin CA, Eshleman JR, Cohen AR, Chakravarti A, Hamosh A, Greider CW. Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc Natl Acad Sci USA. 2005;102(44):15960-15964.
16. Goldman F, Bouarich R, Kulkarni S, Freeman S, Du HY, Harrington L, Mason PJ, Londoño-Vallejo A, Bessler M. The effect of TERC haploinsufficiency on the inheritance of telomere length. Proc Natl Acad Sci USA. 2005;102(47):17119-17124.
17. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR. Telomerase catalytic subunit homologs from fission yeast and human. Science. 1997;15;277(5328):955-959.
18. Heiss NS, Knight SW, Vulliamy TJ, Klauck SM, Wiemann S, Mason PJ, Poustka A, Dokal I. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet. 1998;19(1):32-38.
19. Hassock S, Vetrie D, Giannelli F. Mapping and characterization of the X-linked dyskeratosis congenita (DKC) gene. Genomics. 1999;1;55(1):21-27.
20. Vulliamy T, Marrone A, Szydlo R, Walne A, Mason PJ, Dokal I. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat Genet. 2004;36(5):447-449.
21. Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA, Greider CW. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell. 1997;91(1):25-34.
22. De Boeck K, Degreef H, Verwilghen R, Corbeel L, Casteels- Van Daele M. Thrombocytopenia: First symptom in a patient with dyskeratosis congenita. Pediatrics. 1981;67(6):898-903.